Brucato Antonio, Maestroni Silvia, Cumetti Davide, Thiella Giuseppe, Alari Gabriella, Brambilla Giovanni, Imazio Massimo, Doria Andrea, Palmieri Giancarlo, Adler Yehuda
Department of Internal Medicine, Ospedali Riuniti di Bergamo, Bergamo, Italy.
Autoimmun Rev. 2008 Oct;8(1):44-7. doi: 10.1016/j.autrev.2008.07.024. Epub 2008 Aug 15.
The etiology and pathogenesis of idiopathic recurrent acute pericarditis (IRAP) remain controversial standing like a bridge that crosses infectious, autoimmune and autoinflammatory pathways. Anything may cause acute pericarditis; Echo-virus, and Coxsackie are the most frequently involved viruses, Mycobacterium tuberculosis and Coxiella burnetii the most common bacteria, but in 85% of cases it remains "idiopathic". Recurrences occur in up to 20-50% of patients. An immuno-mediated pathogenesis is suggested by the presence of pro-inflammatory cytokines in pericardial fluid, the presence of antinuclear autoantibodies (ANA) in sera of the patients, the occurrence of new autoimmune diagnoses and the good response to anti-inflammatory or immunosuppressive therapy. Nonsteroidal anti-inflammatory drugs (NSAIDs) must be used at recommended dosages, till the resolution of symptoms and normalization of C-reactive protein and erythrocyte sedimentation rate. Corticosteroids should be used rarely, at low doses, with an extremely low tapering and with osteoporosis prevention. Colchicine leads to a clinically important and statistically significant benefit, reducing recurrences by 50%. The long term outcome of IRAP is good, without evidence of constriction even after a very long follow-up.
特发性复发性急性心包炎(IRAP)的病因和发病机制仍存在争议,它就像一座跨越感染、自身免疫和自身炎症途径的桥梁。任何因素都可能导致急性心包炎;其中,埃可病毒和柯萨奇病毒是最常涉及的病毒,结核分枝杆菌和伯氏考克斯体是最常见的细菌,但在85%的病例中病因仍为“特发性”。高达20%-50%的患者会复发。心包积液中促炎细胞因子的存在、患者血清中抗核自身抗体(ANA)的存在、新的自身免疫性疾病诊断的出现以及对抗炎或免疫抑制治疗的良好反应提示了免疫介导的发病机制。非甾体抗炎药(NSAIDs)必须按推荐剂量使用,直至症状缓解且C反应蛋白和红细胞沉降率恢复正常。应很少使用低剂量的皮质类固醇,减量要极其缓慢,并要预防骨质疏松。秋水仙碱能带来具有临床重要性且在统计学上有显著意义的益处,可将复发率降低50%。IRAP的长期预后良好,即使经过很长时间的随访也没有缩窄的迹象。